Cargando…

Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes

It is unclear whether confounding accounts for the increased risk of preterm birth and small for gestational age (SGA) birth in opioid analgesic exposed pregnancies. METHODS: Using universal coverage health data for Ontario, we assembled a cohort of mother–infant pairs without opioid use disorder (6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brogly, Susan B., Velez, Maria P., Werler, Martha M., Li, Wenbin, Camden, Andi, Guttmann, Astrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Pharmacoepidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011506/ https://www.ncbi.nlm.nih.gov/pubmed/33625160 http://dx.doi.org/10.1097/EDE.0000000000001328

Ejemplares similares

Risk of Postpartum Opioid Use Disorder or Opioid Overdose After Prenatal Opioid Analgesic Use
por: Camden, Andi, et al.
Publicado: (2021)

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study
por: Bowie, Alexa C., et al.
Publicado: (2022)

Causal Effect of Chronic Pain on Mortality Through Opioid Prescriptions: Application of the Front-Door Formula
por: Inoue, Kosuke, et al.
Publicado: (2022)

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019
por: Camden, Andi, et al.
Publicado: (2021)

Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study
por: Chan, Sze Ling, et al.
Publicado: (2016)

Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults
por: Hakkarainen, Katja M, et al.
Publicado: (2014)

Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)

Prenatal opioid exposure and well-child care in the first 2 years of life: population-based cohort study
por: Camden, Andi, et al.
Publicado: (2023)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
por: Blin, Patrick, et al.
Publicado: (2015)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs
por: Root, Adrian A., et al.
Publicado: (2016)

Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study
por: Sørensen, Anne Mette Skov, et al.
Publicado: (2020)

Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug‐induced liver injury case–control study in Italy
por: Donati, Monia, et al.
Publicado: (2016)

Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use
por: Mattioli, Irene, et al.
Publicado: (2022)

Pain severity and analgesics use in the community-dwelling older population: a drug utilization study from Germany
por: Nguyen, Thi Ngoc Mai, et al.
Publicado: (2020)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Validation of suicide and self-harm records in the Clinical Practice Research Datalink
por: Thomas, Kyla H, et al.
Publicado: (2013)

The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015)

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
por: Cressman, Alex M, et al.
Publicado: (2015)

EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016)

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
por: Alping, Peter, et al.
Publicado: (2019)

Patterns of antiplatelet drug use after a first myocardial infarction during a 10‐year period
por: Yasmina, Alfi, et al.
Publicado: (2016)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

Evaluating beneficial drug effects in a non‐interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data
por: Wallerstedt, Susanna M., et al.
Publicado: (2017)

A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU
por: Weatherall, Mary, et al.
Publicado: (2017)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020)

A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients
por: Nateghi, Saeed, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
por: Esposito, Daina B., et al.
Publicado: (2022)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Recognition of adverse drug events in older hospitalized medical patients
por: Klopotowska, Joanna E., et al.
Publicado: (2012)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department
por: Kauppila, Mirjam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nurdlbm5oor93cqs5vcg8f2cie